{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "This was an open-label, randomized clinical trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "This was an open-label, randomized clinical trial conducted at 14 German hospitals."
      },
      "Participants": {
        "score": 2,
        "evidence": "All patients with third- or fourth-degree haemorrhoids undergoing haemorrhoidectomy were considered eligible for selection in the intervention (no dressing) or control group (tamponade applied)."
      },
      "Intervention": {
        "score": 2,
        "evidence": "intervention (no dressing) or control group (tamponade applied)"
      },
      "Objective": {
        "score": 1,
        "evidence": "The aim of the study was to investigate whether the omission of tamponade dressings after haemorrhoidectomy reduces postoperative pain without increasing the risk of severe bleeding."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "maximum pain intensity within 48\u2005h after surgery was compared between the groups"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 3,
        "evidence": "This was an open-label, randomized clinical trial"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "754 were randomized and 725 received intervention (366 patients in the intervention and 359 patients in the control group)"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "754 were randomized and 725 received intervention"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The absolute difference for the severe bleeding rate was \u22120.03 per cent with the 90 per cent confidence interval ranging from \u22121.47 per cent to +1.41 per cent"
      },
      "Harms": {
        "score": 1,
        "evidence": "In each group, five patients (1.4 per cent) experienced severe bleeding."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Registration number: DRKS00011590"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 19,
    "max_score": 25
  },
  "model": "gpt-4o"
}